Shopping Cart No items
Call toll-free : 1-877-385-8998
Monday 11 May 2020
Myrbetriq (mirabegron) is manufactured by Astellas Pharma Inc.
In 2005, the Japanese pharmaceutical companies Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. merged to form Astellas Pharma Inc.
The former was founded in 1923 by Kenji Yamanouchi, and the latter was founded in 1894 by Tomokichi Fujisawa. Both were originally founded in the port city of Osaka.
Today, Astellas Pharma is headquartered in Tokyo, the capital of Japan and the world's most populous metropolis. The company's U.S. headquarters are located in Northbrook, Illinois, and employs about 1,200 people.
Astellas Pharma markets several products in the U.S., all of which fall under five key therapeutic areas:
Urology (the study of the male and female urinary tract, as well as the male reproductive organs).
Myrbetriq was first approved by the Food and Drug Administration (FDA) in 2012 for the treatment of overactive bladder (OAB).
Myrbetriq is unique in that it's the only drug in its class to target the beta-3 pathway. In doing so, it relaxes the muscle that surrounds the bladder and increases the bladder's ability to store urine.
Astellas Pharma manufactures a number of other drugs marketed in the U.S., including:
Buy Myrbetriq online now and have it shipped right to your door.
Weekdays: 9:00 AM - 6:00 PM PSTWeekends: 10:00 AM - 03:00 PM PST